Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name |
DrugCom ID |
Component Drug |
Indication |
REF |
Abexinostat + BMS-754807
|
DCS2NF4
|
Abexinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Afatinib + BMS-754807
|
DCPEH4J
|
Afatinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Belinostat + BMS-754807
|
DC284UN
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
Belinostat + BMS-754807
|
DCX0LF7
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
Belinostat + BMS-754807
|
DCGS75C
|
Belinostat
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
BGJ398 + BMS-754807
|
DCIKFOR
|
BGJ398
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
BGJ398 + BMS-754807
|
DCF0T5U
|
BGJ398
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
BGJ398 + BMS-754807
|
DCCYTSA
|
BGJ398
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
BMS-754807 + Gefitinib
|
DCS4180
|
Gefitinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Gefitinib
|
DCBXGK2
|
Gefitinib
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + Buparlisib
|
DCP69GY
|
Buparlisib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + PD-0325901
|
DC1H1JS
|
PD-0325901
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + PD-0325901
|
DCS2CFH
|
PD-0325901
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + AT13387
|
DCG9QNG
|
AT13387
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Trametinib
|
DC1JBLT
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Trametinib
|
DCR02WS
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[1] |
BMS-754807 + Trametinib
|
DC5574T
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[1] |
BMS-754807 + Trametinib
|
DCWP86P
|
Trametinib
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + JQ1
|
DCUXPF0
|
JQ1
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + JQ1
|
DCYUI3F
|
JQ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + JQ1
|
DCTS3NH
|
JQ1
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[1] |
BMS-754807 + JQ1
|
DCWXF5Y
|
JQ1
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + Carfilzomib
|
DC5JLI3
|
Carfilzomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + PMID28460551-Compound-2
|
DC4D1ND
|
PMID28460551-Compound-2
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Panobinostat
|
DCKDGRH
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Panobinostat
|
DCMKC1I
|
Panobinostat
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Panobinostat
|
DCNJZM6
|
Panobinostat
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + Ixazomib
|
DCNNSIO
|
Ixazomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + RTB101
|
DC2HAYL
|
RTB101
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Alvespimycin hydrochloride
|
DCQM0GG
|
Alvespimycin hydrochloride
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Abexinostat
|
DCJ48NO
|
Abexinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + CA4P
|
DC3Z6AN
|
CA4P
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + CUDC-101
|
DC8T02F
|
CUDC-101
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + PMID25656651-Compound-5
|
DCQ8MEU
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[1] |
BMS-754807 + PMID25656651-Compound-5
|
DC3BX78
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[1] |
BMS-754807 + PMID25656651-Compound-5
|
DC50YSE
|
PMID25656651-Compound-5
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + Cantharidin
|
DCR74YS
|
Cantharidin
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + RAF265
|
DCWVULK
|
RAF265
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + THAPSIGARGIN
|
DCHFFHD
|
THAPSIGARGIN
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + THAPSIGARGIN
|
DC5CYDL
|
THAPSIGARGIN
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + Marizomib
|
DCGXVLA
|
Marizomib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Marizomib
|
DCRKX7Y
|
Marizomib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + SNS-032
|
DCHSYPN
|
SNS-032
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + SNDX-275
|
DCM4B1F
|
SNDX-275
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + SNDX-275
|
DCJD5RX
|
SNDX-275
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + GSK618334
|
DCD8JE3
|
GSK618334
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + AS602868
|
DCZH4EO
|
AS602868
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Tamoxifen
|
DCGYVUN
|
Tamoxifen
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Tamoxifen
|
DCQQIVU
|
Tamoxifen
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + Idarubicin
|
DCOWVAM
|
Idarubicin
|
Glioblastoma? (Cell Line: T98G)
|
[1] |
BMS-754807 + Ciclopirox
|
DCI6I60
|
Ciclopirox
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + Resminostat
|
DC8LVMU
|
Resminostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + IMD-0354
|
DCBJ8IK
|
IMD-0354
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + CF102
|
DCLKY6W
|
CF102
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + BIIB-021
|
DCGQUXT
|
BIIB-021
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
BMS-754807 + BMS-754807
|
DCR91SW
|
BMS-754807
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + Citarinostat
|
DCCNT98
|
Citarinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + PF-562271
|
DCCI9RO
|
PF-562271
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + PF-562271
|
DC9Z4S4
|
PF-562271
|
Embryonal rhabdomyosarcoma (Cell Line: SMS-CTR)
|
[1] |
BMS-754807 + PF-562271
|
DCRX6HS
|
PF-562271
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + PF-562271
|
DC2706X
|
PF-562271
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
BMS-754807 + MK-2206
|
DC1PXTK
|
MK-2206
|
Embryonal rhabdomyosarcoma (Cell Line: SMS-CTR)
|
[1] |
BMS-754807 + MK-2206
|
DC1DPUT
|
MK-2206
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
BMS-754807 + MK-2206
|
DC441HM
|
MK-2206
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[1] |
BMS-754807 + THZ1
|
DC3OL0T
|
THZ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + AZD8330
|
DC43Z36
|
AZD8330
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + Vorinostat
|
DC1BFF0
|
Vorinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
BMS-754807 + CB3304
|
DCWDJJA
|
CB3304
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
CA4P + BMS-754807
|
DC26UV6
|
CA4P
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
Ceritinib + BMS-754807
|
DCIJ9RY
|
Ceritinib
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
Citarinostat + BMS-754807
|
DCNH812
|
Citarinostat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Dasatinib + BMS-754807
|
DCYRJWG
|
Dasatinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Dasatinib + BMS-754807
|
DCIDGK1
|
Dasatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
Dasatinib + BMS-754807
|
DCY1XB7
|
Dasatinib
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
Dorsomorphin + BMS-754807
|
DCLBIKJ
|
Dorsomorphin
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
Dorsomorphin + BMS-754807
|
DC5QY71
|
Dorsomorphin
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
Doxorubicin + BMS-754807
|
DCBBM2L
|
Doxorubicin
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Everolimus + BMS-754807
|
DCL0II0
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[1] |
Everolimus + BMS-754807
|
DC3IED4
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[1] |
Everolimus + BMS-754807
|
DCTADUS
|
Everolimus
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[1] |
Flavopiridol + BMS-754807
|
DCV0VZG
|
Flavopiridol
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
Fostamatinib + BMS-754807
|
DC2ZSP5
|
Fostamatinib
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
GSK2126458 + BMS-754807
|
DCCUU9L
|
GSK2126458
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
GSK2126458 + BMS-754807
|
DCSW4ID
|
GSK2126458
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
GSK2126458 + BMS-754807
|
DC7XIF3
|
GSK2126458
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
IT-141 + BMS-754807
|
DCIYWBI
|
IT-141
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Marimastat + BMS-754807
|
DCXHQ69
|
Marimastat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Mebendazole + BMS-754807
|
DCQBGV6
|
Mebendazole
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Mitapivat + BMS-754807
|
DCD4B0T
|
Mitapivat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
MK-1775 + BMS-754807
|
DC7HRPI
|
MK-1775
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
MK-2206 + BMS-754807
|
DCYH6XO
|
MK-2206
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
MLN8237 + BMS-754807
|
DC819RJ
|
MLN8237
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
ONC201 + BMS-754807
|
DCGVQZG
|
ONC201
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Palbociclib + BMS-754807
|
DC29FGP
|
Palbociclib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
PD-0325901 + BMS-754807
|
DC9VZXK
|
PD-0325901
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
PHA848125 + BMS-754807
|
DCHMSDZ
|
PHA848125
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Raloxifene + BMS-754807
|
DCF05DZ
|
Raloxifene
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
Raloxifene + BMS-754807
|
DC9EWAV
|
Raloxifene
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
Ribavirin-TP + BMS-754807
|
DC1839J
|
Ribavirin-TP
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
RTB101 + BMS-754807
|
DCCU8JN
|
RTB101
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
RTB101 + BMS-754807
|
DC4NMG7
|
RTB101
|
Primitive neuroectodermal tumor (Cell Line: TC-32)
|
[1] |
SCH 727965 + BMS-754807
|
DC9SBLG
|
SCH 727965
|
Diffuse intrinsic pontine glioma (Cell Line: SU-DIPG-XIII)
|
[1] |
SCH772984 + BMS-754807
|
DCGOX4N
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: Rh36)
|
[2] |
SCH772984 + BMS-754807
|
DCPNVDS
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: CTR)
|
[2] |
SCH772984 + BMS-754807
|
DCJDGPY
|
SCH772984
|
Embryonal rhabdomyosarcoma (Cell Line: RD)
|
[2] |
Teriflunomide + BMS-754807
|
DCIP3M8
|
Teriflunomide
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
THAPSIGARGIN + BMS-754807
|
DC5E51X
|
THAPSIGARGIN
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
THZ1 + BMS-754807
|
DCN6XA4
|
THZ1
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Tosyl-l-arginine methyl ester + BMS-754807
|
DCVMFRD
|
Tosyl-l-arginine methyl ester
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Trametinib + BMS-754807
|
DC0T4P3
|
Trametinib
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[2] |
Venglustat + BMS-754807
|
DCBZ3WS
|
Venglustat
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
Vincristine + BMS-754807
|
DCGU2LS
|
Vincristine
|
Diffuse intrinsic pontine glioma (Cell Line: DIPG25)
|
[1] |
------------------------------------------------------------------------------------ |
|
|
|
|